Tongke Tang

机构：Guangzhou Institutes of Biomedicine and Health

发表论文 13 篇 · 总被引 227 次 · h-index 8

代表论文

• A novel multistage antiplasmodial inhibitor targeting Plasmodium falciparum histone deacetylase 1 (2020 · Cell Discovery · 被引 57)
• Discovery of Novel Plasmodium falciparum HDAC1 Inhibitors with Dual-Stage Antimalarial Potency and Improved Safety Based on the Clinical Anticancer Drug Candidate Quisinostat (2021 · Journal of Medicinal Chemistry · 被引 45)
• Drug Repurposing of Quisinostat to Discover Novel Plasmodium falciparum HDAC1 Inhibitors with Enhanced Triple-Stage Antimalarial Activity and Improved Safety (2022 · Journal of Medicinal Chemistry · 被引 35)
• Targeting METTL3 as a checkpoint to enhance T cells for tumour immunotherapy (2024 · Clinical and Translational Medicine · 被引 23)
• Ten-Year Molecular Surveillance of Drug-Resistant Plasmodium spp. Isolated From the China–Myanmar Border (2021 · Frontiers in Cellular and Infection Microbiology · 被引 19)
• Design, synthesis, and biological evaluation of multiple targeting antimalarials (2021 · Acta Pharmaceutica Sinica B · 被引 16)